RQM+ provides deep regulatory and clinical expertise for in vitro diagnostic (IVD) manufacturers, with fully integrated support across EU IVDR and U.S. FDA requirements. From strategic planning through post-market performance follow-up (PMPF), our MedTech-only team helps de-risk development, accelerate submissions, and support global market success

  • MedTech-Only CRO

    100% focused on medical devices and diagnostics.

  • Regulatory and Clinical Integration

    End-to-end alignment across regulatory strategy, clinical performance, and market access.

  • True IVDR Experts

    Scientific validity, classification, PERs, and compliance with Annexes I, XIII, and XIV.

  • FDA Compliance

    U.S. regulatory strategy aligned with 21 CFR Parts 807, 809, 812, 820, and more.

  • Life Cycle Support

    From design through post-market surveillance and notified body audits.

Standards We Navigate

  • EU IVDR (Regulation EU 2017/746)

  • ISO 13485 – Quality Management Systems for Medical Devices

  • ISO 15189 – Medical Laboratories – Requirements for Quality and Competence

  • ISO 20916 – Clinical Performance Studies of IVDs

  • FDA 21 CFR Parts 11, 50, 56, 58, 807, 809, 812, 820

  • CLSI EP Series Guidelines (e.g., EP05, EP07, EP09)

  • GDPR and IVDR Article 61 – Data protection in EU clinical research

Expand each to see our key services.

  • IVDR/FDA classification and regulatory pathway mapping
  • Scientific validity strategy
  • Preliminary performance planning
  • Early coding and HTA feasibility
  • Assay validation planning
  • Development of Performance Evaluation Plan (PEP)
  • PER and SVR structure setup
  • Study feasibility planning (ISO 20916)
  • Market access alignment (CPT/PLA coding, value proposition) 
  • Analytical and clinical validation (CLSI and ISO 20916)
  • Performance Evaluation Report (PER) drafting
  • Data traceability and gap analysis
  • Payer-aligned endpoint justification
  • Clinical study support
  • Usability and CLIA waiver requirements
  • Raw material traceability
  • Batch testing protocols for IVDR Annex IX
  • Manufacturing QMS compliance (ISO 13485)
  • Notified body audit preparation
  • Compilation of EU IVDR Technical Documentation
  • Performance Study Applications and IDEs for interventional studies
  • Finalization of PER, SVR, and Annex XIV content
  • UKCA readiness
  • FDA PMA/de novo/510(k) preparation for U.S. market
  • CLIA waiver dual applications for FDA
  • Post-Market Performance Follow-Up (PMPF) plans and execution
  • Periodic Safety Update Reports (PSURs)
  • Real-world evidence capture
  • Coding and pricing surveillance
  • Regulatory impact assessment under Article 56
  • PER and SVR updates
  • Clinical evidence refresh for performance modifications
  • Reimbursement documentation revisions
  • PLA/CPT/DRG coding strategy
  • HTA dossier development (e.g., NICE, G-BA)
  • CMS/NUB application support
  • Payer feedback tracking and price justification
Full-Service Outsourcing

Full-Service Outsourcing

End-to-end project ownership, from strategy to execution. Our managed outsourcing solutions enable easy collaboration, streamlined operations, and expert oversight so you can focus on what you do best.

Professional Consulting

Professional Consulting

Industry-leading MedTech consultants with the strategic insight and regulatory expertise to solve your toughest challenges. Our global team stays ahead of evolving regulations to keep your innovations moving forward.

Professional Staffing

Professional Staffing

Need an expert or a full team? We provide highly qualified MedTech professionals who integrate quickly and easily into your organization — the right people, right when you need them.

Ready to Simplify IVD Compliance and Accelerate Market Access?

Let RQM+ be your partner for strategy, execution, and compliance — from concept to post-market. We make the complex simple for IVD innovators.

Contact us to schedule a discovery call with our diagnostics team.

Talk to an Expert